• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体内前列腺癌细胞雄激素去除后bcl-2增强生长的分子关联

Molecular correlates of bcl-2-enhanced growth following androgen-ablation in prostate carcinoma cells in vivo.

作者信息

Beham A W, Sarkiss M, Brisbay S, Tu S M, von Eschenbach A C, McDonnell T J

机构信息

Department of Molecular Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

出版信息

Int J Mol Med. 1998 Jun;1(6):953-9. doi: 10.3892/ijmm.1.6.953.

DOI:10.3892/ijmm.1.6.953
PMID:9852630
Abstract

Androgen-independent growth of prostate cancer is correlated with expression of bcl-2. The impact of bcl-2 expression on the growth of prostate cancer cells following androgen ablation, was examined in the androgen-sensitive prostatic carcinoma cell line, LNCaP. Vector control and bcl-2 expressing LNCaP cells were grown subcutaneously in male nude mice. Tumor volume, apoptosis, and proliferation were assessed following castration. The levels of c-myc, p53, p21, bax, and bcl-2 protein were assessed by Western blotting. Bcl-2 expressing tumors exhibited a significant augmentation in growth compared to controls (p 0.01). No difference in the spontaneous rate of proliferation was observed between bcl-2 and control tumors, however, bcl-2 expressing tumors exhibited lower rates of apoptosis. Following orchiectomy the apoptotic index remained significantly lower in bcl-2 expressing tumors (p 0.002 at day 3). The proliferative index was maintained in bcl-2 expressing, but not control tumors following castration. This resulted in a significant growth advantage in bcl-2 tumors subsequent to androgen ablation (p 0.001). These changes were accompanied by alterations in the levels of gene products known to regulate the cell cycle and/or apoptosis. These results emphasize the significance of bcl-2 expression during prostate cancer progression and suggest possible mechanisms for the acquisition of androgen-independent tumor growth.

摘要

前列腺癌的雄激素非依赖性生长与bcl-2的表达相关。在雄激素敏感的前列腺癌细胞系LNCaP中,研究了bcl-2表达对雄激素去除后前列腺癌细胞生长的影响。将载体对照和表达bcl-2的LNCaP细胞接种于雄性裸鼠皮下。去势后评估肿瘤体积、凋亡和增殖情况。通过蛋白质印迹法评估c-myc、p53、p21、bax和bcl-2蛋白的水平。与对照相比,表达bcl-2的肿瘤生长显著增加(p<0.01)。在bcl-2和对照肿瘤之间未观察到自发增殖率的差异,然而,表达bcl-2的肿瘤凋亡率较低。去势后,表达bcl-2的肿瘤凋亡指数在第3天仍显著较低(p<0.002)。去势后,表达bcl-2的肿瘤维持增殖指数,但对照肿瘤则不然。这导致雄激素去除后bcl-2肿瘤具有显著的生长优势(p<0.001)。这些变化伴随着已知调节细胞周期和/或凋亡的基因产物水平的改变。这些结果强调了bcl-2表达在前列腺癌进展过程中的重要性,并提示了获得雄激素非依赖性肿瘤生长的可能机制。

相似文献

1
Molecular correlates of bcl-2-enhanced growth following androgen-ablation in prostate carcinoma cells in vivo.体内前列腺癌细胞雄激素去除后bcl-2增强生长的分子关联
Int J Mol Med. 1998 Jun;1(6):953-9. doi: 10.3892/ijmm.1.6.953.
2
TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.TabBO:一种反映去势抵抗性前列腺癌常见分子特征的模型。
Clin Cancer Res. 2000 Mar;6(3):1190-7.
3
Synergistic chemosensitization and inhibition of progression to androgen independence by antisense Bcl-2 oligodeoxynucleotide and paclitaxel in the LNCaP prostate tumor model.在LNCaP前列腺肿瘤模型中,反义Bcl-2寡脱氧核苷酸与紫杉醇协同作用的化学增敏及抑制向雄激素非依赖性进展的研究
Int J Cancer. 2001 Mar 15;91(6):846-50. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1131>3.0.co;2-y.
4
Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo.bcl-2的过表达在体外可保护前列腺癌细胞免于凋亡,并在体内赋予对雄激素剥夺的抗性。
Cancer Res. 1995 Oct 1;55(19):4438-45.
5
Effect of Bcl-2 overexpression in human prostate cancer cells in vitro and in vivo.
Int J Urol. 1999 Oct;6(10):520-5. doi: 10.1046/j.1442-2042.1999.00102.x.
6
Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.肾母细胞瘤抑癌基因WT1在体内对前列腺肿瘤细胞生长的抑制作用
Int J Oncol. 2004 Mar;24(3):461-71.
7
Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model.在LNCaP前列腺肿瘤模型中,去势后用反义Bcl-2寡脱氧核苷酸进行辅助治疗可延迟向雄激素非依赖性进展。
Clin Cancer Res. 1999 Oct;5(10):2891-8.
8
The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.新型抗微管药物隐藻素52(LY355703)通过多种途径诱导人前列腺癌细胞凋亡。
Clin Cancer Res. 2002 Dec;8(12):3922-32.
9
Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.腺病毒载体递送的Bax在前列腺中的特异性表达可诱导LNCaP前列腺癌细胞凋亡。
Gene Ther. 2001 Sep;8(18):1363-71. doi: 10.1038/sj.gt.3301531.
10
Androgen-independent growth of LNCaP prostate cancer cells is mediated by gain-of-function mutant p53.LNCaP前列腺癌细胞的雄激素非依赖性生长由功能获得性突变型p53介导。
Cancer Res. 2003 May 1;63(9):2228-33.

引用本文的文献

1
Identification of the inhibitor of growth protein 4 (ING4) as a potential target in prostate cancer therapy.鉴定生长抑制因子 4(ING4)作为前列腺癌治疗的潜在靶点。
Mol Cell Biochem. 2020 Jan;464(1-2):153-167. doi: 10.1007/s11010-019-03657-x. Epub 2019 Nov 27.
2
Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02.根据放射肿瘤学组92 - 02方案接受雄激素剥夺和放射治疗的男性中,Bcl - 2和Bax表达可预测前列腺癌的预后。
Clin Cancer Res. 2007 Jun 15;13(12):3585-90. doi: 10.1158/1078-0432.CCR-06-2972.
3
Antisense Bcl-2 sensitizes prostate cancer cells to radiation.
反义Bcl-2使前列腺癌细胞对辐射敏感。
Prostate. 2005 Dec 1;65(4):331-40. doi: 10.1002/pros.20303.
4
Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell lines.细胞周期蛋白依赖性激酶(CDK)的合成抑制剂在雄激素敏感和雄激素不敏感的前列腺癌细胞系中会引发不同的反应。
Mol Pathol. 2002 Aug;55(4):227-34. doi: 10.1136/mp.55.4.227.